{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_004192.4:c.6058A>C",
          "cDNA Change": {
            "transcript": "NM_004192.4",
            "ref": "A",
            "alt": "C",
            "position": "6058"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T mutation in the kinase domain of LRRK2"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004684"
  },
  "Experiment Method": [
    {
      "Assay Method": "Apoptosis Assay (Hydrogen Peroxide-Induced)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Not specified (assumed to be human cell line)",
        "Description": "Experiments involved hydrogen peroxide-induced apoptosis and proteolysis inhibitor treatment."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004192.4:c.6058A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired protective function against apoptosis",
          "Result Description": "I2020T mutant showed reduced protective effect against hydrogen peroxide-induced apoptosis, which was partially restored by proteolysis inhibitors."
        },
        {
          "Variant": "Wild-type LRRK2",
          "Conclusion": "Normal",
          "Molecular Effect": "Protective function against apoptosis",
          "Result Description": "Knockdown of wild-type LRRK2 reduced protective effect against apoptosis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Replicates not explicitly mentioned in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Replicates not explicitly mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for protective function."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Proteolysis inhibitor-treated cells or knockdown controls were used as experimental controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protective effect â‰¥ 80% compared to control cells",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protective effect < 50% compared to control cells",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}